Home / Asia-Pacific / China / Life Sciences & Healthcare / Life Sciences & Healthcare Lawyers

Life Sciences & Healthcare Lawyers

As a participant in the lifesciences industry, you know that discovery and innovation are key to finding lasting health solutions. Yet due to the highly regulated nature of the industry, you - a corporate, investor or start-up - must overcome complex administrative, compliance and liability hurdles before your products and services can come to market. With over 150 international specialists across CMS and the support of the Lifesciences Asia-Pacific Network (LAN), we understand the scientific and commercial as well as the legal imperatives affecting your business.

Our experts, many of whom have worked in-house in your sector, have developed a shared capability in the areas of pharmaceuticals, biotechnology, medical devices and diagnostics. With active memberships in the major industry associations such as the ABPI, ABHI, BIVDA, PAGB, EUCOMED and EFPIA, we help shape the legal frameworks impacting the lifesciences sector. We regularly advise our clients on their day to day operational needs such as support with public sector procurement, patent prosecution and enforcement, commercial agreements, tax and transfer pricing, and regulatory advice. Equally, when you need lifesciences specialist advice for strategic agreements, planning a corporate transaction or embarking on litigation (whether product liability or otherwise), we have a team that is well versed in the industry issues to help you.

Nicolas Zhu
Nicolas Zhu
Head of Lifesciences and Healthcare Sector Group, CMS Hasche Sigle Shanghai Representative Office (Germany)
China, Shanghai
Nicolas Zhu’s practice covers all aspects of corporate, intellectual property and other matters affecting Life Sciences and Healthcare clients. He has been advising clients on issues in relation to...
Roxie Meng
Roxie Meng
Senior Associate
China, Beijing
Roxie Meng is a senior associate in Beijing. She specialises in a range of corporate and commercial related matters, including foreign direct investment, cross-border M&A transactions, outbound investment...